Dimensional Fund Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.6M | Buy |
573,688
+47,046
| +9% | +$2.51M | 0.01% | 1772 |
|
|
2025
Q1 | $21.3M | Buy |
526,642
+77,532
| +17% | +$3.14M | 0.01% | 1920 |
|
|
2024
Q4 | $12.5M | Buy |
449,110
+442,014
| +6,229% | +$12.3M | ﹤0.01% | 2216 |
|
|
2024
Q3 | $204K | Sell |
7,096
-11,066
| -61% | -$317K | ﹤0.01% | 3170 |
|
|
2024
Q2 | $426K | Sell |
18,162
-27,274
| -60% | -$640K | ﹤0.01% | 3047 |
|
|
2024
Q1 | $1.15M | Buy |
45,436
+24,493
| +117% | +$619K | ﹤0.01% | 2900 |
|
|
2023
Q4 | $489K | Sell |
20,943
-81,477
| -80% | -$1.9M | ﹤0.01% | 3044 |
|
|
2023
Q3 | $5.18M | Sell |
102,420
-166,497
| -62% | -$8.42M | ﹤0.01% | 2521 |
|
|
2023
Q2 | $12.6M | Sell |
268,917
-14,599
| -5% | -$682K | ﹤0.01% | 2153 |
|
|
2023
Q1 | $10.8M | Sell |
283,516
-7,090
| -2% | -$271K | ﹤0.01% | 2200 |
|
|
2022
Q4 | $15.9K | Sell |
290,606
-785
| -0.3% | -$43 | ﹤0.01% | 1976 |
|
|
2022
Q3 | $9.92M | Sell |
291,391
-70,597
| -20% | -$2.4M | ﹤0.01% | 2156 |
|
|
2022
Q2 | $3.42M | Buy |
361,988
+24,198
| +7% | +$229K | ﹤0.01% | 2572 |
|
|
2022
Q1 | $4.79M | Buy |
337,790
+85,525
| +34% | +$1.21M | ﹤0.01% | 2545 |
|
|
2021
Q4 | $5.34M | Buy |
252,265
+42,019
| +20% | +$889K | ﹤0.01% | 2543 |
|
|
2021
Q3 | $4.7M | Sell |
210,246
-4,816
| -2% | -$108K | ﹤0.01% | 2608 |
|
|
2021
Q2 | $5.34M | Buy |
215,062
+182,368
| +558% | +$4.52M | ﹤0.01% | 2593 |
|
|
2021
Q1 | $948K | Sell |
32,694
-16,640
| -34% | -$482K | ﹤0.01% | 3024 |
|
|
2020
Q4 | $1.27M | Buy |
+49,334
| New | +$1.27M | ﹤0.01% | 2927 |
|